Integrated Quantitative Investments LLC Acquires New Holdings in Genpact Limited (NYSE:G)

Integrated Quantitative Investments LLC bought a new position in Genpact Limited (NYSE:G) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 18,900 shares of the business services provider’s stock, valued at approximately $812,000.

Several other hedge funds have also modified their holdings of G. Cerity Partners LLC lifted its holdings in shares of Genpact by 136.4% during the 3rd quarter. Cerity Partners LLC now owns 17,935 shares of the business services provider’s stock valued at $703,000 after purchasing an additional 10,349 shares during the last quarter. BNP Paribas Financial Markets increased its position in Genpact by 78.8% during the 3rd quarter. BNP Paribas Financial Markets now owns 47,957 shares of the business services provider’s stock valued at $1,880,000 after buying an additional 21,140 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new stake in Genpact in the third quarter valued at about $4,365,000. Verition Fund Management LLC boosted its holdings in Genpact by 139.2% in the third quarter. Verition Fund Management LLC now owns 26,268 shares of the business services provider’s stock worth $1,030,000 after acquiring an additional 15,285 shares in the last quarter. Finally, HighTower Advisors LLC purchased a new stake in shares of Genpact during the third quarter worth about $232,000. 96.03% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research firms recently commented on G. Needham & Company LLC lifted their target price on shares of Genpact from $55.00 to $65.00 and gave the stock a “buy” rating in a research note on Friday, February 7th. Jefferies Financial Group upgraded shares of Genpact from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $44.00 to $55.00 in a research note on Tuesday, January 21st. Mizuho upped their target price on Genpact from $45.00 to $55.00 and gave the company a “neutral” rating in a research report on Monday, February 10th. Finally, TD Cowen raised Genpact from a “hold” rating to a “buy” rating and lifted their price target for the stock from $45.00 to $60.00 in a research report on Friday, February 7th. Six analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $48.44.

Insider Activity

In other news, SVP Piyush Mehta sold 12,000 shares of the business’s stock in a transaction dated Friday, January 10th. The shares were sold at an average price of $42.83, for a total transaction of $513,960.00. Following the completion of the sale, the senior vice president now owns 151,182 shares of the company’s stock, valued at $6,475,125.06. The trade was a 7.35 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Balkrishan Kalra sold 13,600 shares of the firm’s stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $48.89, for a total transaction of $664,904.00. Following the completion of the transaction, the chief executive officer now directly owns 310,246 shares in the company, valued at $15,167,926.94. This represents a 4.20 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 2.80% of the company’s stock.

Genpact Stock Down 3.7 %

Shares of G opened at $47.08 on Friday. The stock’s 50-day moving average price is $51.20 and its 200-day moving average price is $45.39. The company has a quick ratio of 1.85, a current ratio of 2.16 and a debt-to-equity ratio of 0.50. The company has a market capitalization of $8.27 billion, a price-to-earnings ratio of 16.58, a PEG ratio of 1.84 and a beta of 1.06. Genpact Limited has a 52 week low of $30.23 and a 52 week high of $56.76.

Genpact (NYSE:G) last issued its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.82 EPS for the quarter, missing analysts’ consensus estimates of $0.86 by ($0.04). Genpact had a return on equity of 22.50% and a net margin of 10.77%. On average, sell-side analysts predict that Genpact Limited will post 3.21 EPS for the current year.

Genpact Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, March 26th. Stockholders of record on Tuesday, March 11th were paid a dividend of $0.17 per share. This is a positive change from Genpact’s previous quarterly dividend of $0.15. This represents a $0.68 annualized dividend and a dividend yield of 1.44%. The ex-dividend date of this dividend was Tuesday, March 11th. Genpact’s dividend payout ratio is presently 23.94%.

About Genpact

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.